# Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

> **NCT00049595** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 552 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** pegfilgrastim
- **DRUG:** ABVD regimen
- **DRUG:** BEACOPP regimen
- **DRUG:** cyclophosphamide
- **DRUG:** dacarbazine
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** prednisone
- **DRUG:** procarbazine hydrochloride
- **DRUG:** vinblastine sulfate
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00049595
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2010-01
- **Final completion:** —
- **Target enrollment:** 552 (ACTUAL)
- **Last updated:** 2025-08-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00049595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00049595, "Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00049595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*